Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 02, 2008. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding equity awards rather than a financial performance report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document details a specific increase in interests in American Depository Shares (ADSs) for Claudine Bruck Slaoui.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly reports the award of 2,980 nil-priced restricted shares under the Company's Share Value Plan on July 23, 2008. The restriction period for these ADSs commenced on July 23, 2008, and expires on July 22, 2011.
Key Facts for Investor Verification
- Recipient of equity award: Claudine Bruck Slaoui.
- Award type: 2,980 nil-priced restricted shares under the Share Value Plan.
- Award date: July 23, 2008.
- Restriction expiration date: July 22, 2011.
- Document type: Notification of director/managerial transactions (Form 6-K).